OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Science is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Issue Information	565
Issue Information	143
Issue Information	103
Issue Information	100
A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection‐Enhanced Delivery in Children With DIPG	85
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide syn	83
Correction to “Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK	79
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer	77
Correction to “ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood”	74
GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A	72
Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation	70
Issue Information	68
Retraction	65
LHPP‐P38 MAPK/ERK‐ETS1 Axis Negative Feedback Signaling Restrains Progression in Breast Cancer	64
Comparison of ¹¹C‐Acetate and ¹⁸F‐FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma	64
Susceptibility of Brca1^(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer	63
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test	58
Novel CHI3L1‐Associated Angiogenic Phenotypes Define Glioma Microenvironments: Insights From Multi‐Omics Integration	55
A Contrast‐Enhanced Ultrasound Cine‐Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapie	54
TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation	54
	54
LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer	52
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8⁺ T cell infiltration in melanoma	52
TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner	51
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center	49

Efficacy and biomarker analysis of second‐line nab‐paclitaxel plus sintilimab in patients with advanced biliary tract cancer	47
The emerging multifaceted role of PINK1 in cancer biology	46
Induction of immunogenic cell death in murine colon cancer cells by ferrocene‐containing redox phospholipid polymers	45
Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma	45
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes	44
EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment	44
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial	43
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders	43
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine	42
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors	41
Novel and efficient method for culturing patient‐derived gastric cancer stem cells	41
Tumor‐associated macrophage‐derived transforming growth factor‐β promotes colorectal cancer progression through HIF1‐TRIB3 signaling	40
Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synt	39
Dysregulated minor intron splicing in cancer	39
Thrombospondin‐1 induced programmed death‐ligand 1‐mediated immunosuppression by activating the STAT3 pathway in osteosarcoma	39
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9	38
Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells	38
Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis	38
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system	37
PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development	37
Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth	37
PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway	36
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner	36
In This Issue	35
Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea	35
In this issue	35
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017	35
CDX2 Promoter‐Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer	34
Correction	34
Correction to “G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor”	34
Issue Information	34
In This Issue	34
Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity	33
Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis	33
Issue Information	33
Multiplex plasma protein assays as a diagnostic tool for lung cancer	32
When and how should next‐generation sequencing and comprehensive genomic profiling assays be performed?	32
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy	31
Biological effectiveness and relative biological effectiveness of ion beams for in‐vitro cell irradiation	31
Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases	31
Concerning trends and potential issues in osteosarcoma research publication	31
Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif‐containing 37‐induced tumor necrosis factor receptor‐associated factor 2 ubiquitination	31
Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer	30
Chronological improvement in precision oncology implementation in Japan	30
Prognostic impact of the presence or absence of prior cancer in patients with cancer using cure models: A population‐based study	30
Effect of fasting on cancer: A narrative review of scientific evidence	30
C644‐0303, a small‐molecule inhibitor of the Wnt/β‐catenin pathway, suppresses colorectal cancer growth	30
FZD10‐targeted α‐radioimmunotherapy with ²²⁵Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model	29
Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence	29
MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma	29

Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation	29
Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer	29
Pleckstrin‐2‐promoted PPM1B degradation plays an important role in transforming growth factor‐β‐induced breast cancer cell invasion and metastasis	29
Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer	29
LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression	29
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma	29
Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network	28
Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis	27
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas	27
Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer	27
A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice	26
Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma	26
Selective autophagy	26
Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3	26
Diversity of U1 Small Nuclear RNAs and Diagnostic Methods for Their Mutations	26
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo	26
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling	26
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis	26
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816	26
Genotype–phenotype correlation for extracolonic aggressive phenotypes in patients with familial adenomatous polyposis	26
Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial	26
HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer	26
	26
In this issue	26
	25
Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer	25
Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy	25
Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron‐Dependent PI3K/AKT/mTOR Signaling Pathway	25
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer	25
Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies	25
IL‐27 improves adoptive CD8⁺ T cells’ antitumor activity via enhancing cell survival and memory T cell differentiation	25
BBOX1‐AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial–mesenchymal transition process	25
	25
Evaluating the effect of childhood sunburn on the risk of cutaneous melanoma through Mendelian randomization	25
Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity	24
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ	24
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR‐33a/b to disinhibit PD‐L1	24
Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics	24
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor	24
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma	24
Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA‐152‐3p and regulating E2F3/MAPK8 signaling	23
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan	23
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer	23
Methyltransferase like‐14 suppresses growth and metastasis of non‐small‐cell lung cancer by decreasing LINC02747	23
Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer	23
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer	23
Rev1 overexpression accelerates N‐methyl‐N‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis	23
Growth pattern of de novo small clusters of colorectal cancer is regulated by Notch signaling at detachment	23
C/EBPβ induces B‐cell acute lymphoblastic leukemia and cooperates with BLNK mutations	23
M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potent	23
Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis	23
RNA‐binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program	22
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer	22
Association between adherence to Eat‐Lancet diet and incidence and mortality of lung cancer: A prospective cohort study	22
GADD45β‐MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways	22
PD‐1 blockade treatment in melanoma: Mechanism of response and tumor‐intrinsic resistance	22
Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer	22
CD44v5 domain regulates crosstalk between TNBC cells and tumor‐associated macrophages by enhancing the IL‐4R/STAT3 axis	22
In this issue	22
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN‐Amplified Neuroblastoma	22
Cholesterol synthesis is essential for the growth of liver metastasis‐prone colorectal cancer cells	22
Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi‐institutional study	22
Correction to Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal cell carcinoma progression by regulating SOX12	22
In this Issue	22
Abstracts	22
Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores	21
	21
Fat mass and obesity‐associated protein regulates arecoline‐exposed oral cancer immune response through programmed cell death‐ligand 1	21
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast	21
Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression	21
In this issue	21
In Vitro Expansion and Transduction of Primary NK Cells Using Feeder Cells Expressing Costimulatory Molecules and IL‐21	21
Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities	21
Dysfunction of CD8⁺ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients	21
Mutation Analysis of TMB‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications	21
Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors	21
Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)	21
Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma	21
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)	20
A nationwide birth year‐by‐year analysis of effectiveness of HPV vaccine in Japan	20

	20
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome	20
Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015	20
Attitudes toward cancer screening in regional Japan during the COVID‐19 pandemic: An anonymous survey	20
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma	20
Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma	20
	20
SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1	20
PSMD14/E2F1 Axis‐Mediated CENPF Promotes the Metastasis of Triple‐Negative Breast Cancer Through Inhibiting Ferroptosis	20
Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS)	20
Neon ion (²⁰Ne¹⁰⁺) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models	20
Novel LAMC2 fusion protein has tumor‐promoting properties in ovarian carcinoma	20
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L	20
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells	20
ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2	19
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*	19
Issue Information	19
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice	19
Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study	19
Metabolic stress‐induced reciprocal loop of long noncoding RNA ZFAS1 and ZEB1 promotes epithelial–mesenchymal transition and metastasis of pancreatic cancer cells	19
Activated macrophages promote invasion by early colorectal cancer via an interleukin 1β‐serum amyloid A1 axis	19
Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction	19
Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas	19
Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer	19
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2	19
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRI	19
Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS	19
Multiple‐level copy number variations in cell‐free DNA for prognostic prediction of HCC with radical treatments	19
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort	18
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia	18
A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer	18
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma	18
Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study	18
A combination of lymphatic drug delivery of anti‐CTLA‐4 antibody and local radiotherapy for solid‐tumor treatment	18
Serum untargeted metabolomics reveal metabolic alteration of non‐small cell lung cancer and refine disease detection	18
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance	18
Single‐cell transcriptomic analysis of gingivo‐buccal oral cancer reveals two dominant cellular programs	18
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments	18
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene	18
Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library	18
Intratumor heterogeneity of lymphoma identified by multiregion sequencing of autopsy samples	18
MED27 plays a tumor‐promoting role in breast cancer progression by targeting KLF4	18
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma	18
Senescence and senolysis in cancer: The latest findings	18
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	18
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells	18
Transcriptional suppression of Dicer by HOXB‐AS3/EZH2 complex dictates sorafenib resistance and cancer stemness	18
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth	18
Adaptive use of error‐prone DNA polymerases provides flexibility in genome replication during tumorigenesis	18
Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis	18
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients	18
CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma	18
Spatial omics technologies for understanding molecular status associated with cancer progression	18
Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies	18
A Novel Method for Prognostic Risk Classification After Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Using Data‐Mining Methods	17
Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab	17
Senescent CD8⁺ T cells acquire NK cell‐like innate functions to promote antitumor immunity	17
CORRECTION	17
	17
STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy	17
Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC‐Dependent Ca²⁺/ERK Signaling Activation	17
In this issue	17
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAFV600E Mutated Lung Adenocarcinoma via Survivin Downregulation	17
Correction	17
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia	17
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia	17
CORRECTION	17
RETRACTION: MicroRNA‐16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor‐κB1/MMP9 signaling pathway	17
AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts	17
Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway	16
CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop	16
The cancer epigenome: Non‐cell autonomous player in tumor immunity	16
Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma	16
Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells	16
Patient survey on cancer genomic medicine in Japan under the national health insurance system	16
Long‐term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real‐world data	16
circEZH2^E2^/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression	16
Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old	16
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study	16
Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis	16
Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation‐dependent probe amplification	16
Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth	16
Dual targeted therapy with pyrotinib and trastuzumab forHER2‐positive advanced colorectal cancer: A phase 2 trial	16
MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer	16
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis	16
Trends in patterns of treatment and survival of colorectal cancer patients using cancer registry data in Japan: 1995–2015	16
CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene	16
Cross‐talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis	16
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: ¹⁸F‐labeled rBC2LCN lectin	15
In this issue	15
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine	15
In this issue	15
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract	15
In this issue	15
Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1	15